Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis

Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis: An Infant Cohort Study - Analysis of Intestinal/Skin Microbiota and Blood Markers during the Transition from Infantile Eczema to Atopic Dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056270

Enrollment

200

Registered

2024-12-01

Start date

2024-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis/Eczema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Male and female infants aged 0-1 month who have skin problems such as infantile eczema upon visiting the clinic. (2) Those whose guardians have received an explanation of the study, are able to understand its contents, and can provide written consent.

Exclusion criteria

Exclusion criteria: (1) Those with a history of serious illness. (2) Those who have taken or applied antibiotics within one month prior to obtaining consent. (3) Those who have treated eczema with medications other than moisturizers, such as steroids, before participating in the study. (4) Those who are deemed ineligible by the study representative or principal investigator.

Design outcomes

Primary

Measure	Time frame
No medical efficacy or safety evaluations will be conducted in this study.	—

Countries

Japan

Contacts

Public ContactShinji Fukuda

Keio University Institute of Advanced Bioscience

sfukuda@sfc.keio.ac.jp0235-29-0528

Outcome results